Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAFV600E mutation‐prevalent area

Chung, Ki‐wook, Yang, Sun Kyung, Lee, Geon Kook, Kim, Eun Young, Kwon, Soim, Lee, Sang Hyun, Park, Do Joon, Lee, Hyun Sook, Cho, Bo Youn, Lee, Eun Sook, Kim, Sun Wook·2006·Clinical Endocrinology

Abstract

Summary: Background Between 10 and 30% of the fine needle aspiration biopsies (FNABs) of thyroid nodules are diagnosed as ‘indeterminate’. A molecular diagnostic method is needed to reduce unnecessary surgery in this group. In Korea, most thyroid cancer is the classic papillary type and the BRAF V600E mutation is highly prevalent. Aim To evaluate the role of pre‐operative detection of BRAF V600E mutation in the FNAB specimens of thyroid nodules in a BRAF V600E mutation‐prevalent geographical area. Patients and methods In 137 specimens of FNAB (107 papillary thyroid carcinomas (PTC); 3 follicular thyroid carcinomas (FTC); 2 undifferentiated thyroid carcinomas; 25 benign lesions), both direct DNA sequencing and PCR‐RFLP were used for detecting the BRAF V600E mutation. The sensitivity and specificity were calculated. We analysed the association between BRAF V600E mutation and the clinico‐pathological parameters. Results The BRAF V600E mutation was present in 93 (83%) of 112 thyroid cancers. Direct DNA sequencing showed a sensitivity of 83·0% and a specificity of 96·0%. The sensitivity and specificity of PCR‐RFLP were 78·6% and 80·0%, respectively. Among 25 cases with indeterminate FNAB cytology, 8 patients had malignant lesions (5 PTC and 3 FTC). Three (60%) of 5 PTCs and 1 out of 17 benign lesions had BRAF V600E mutation (only one false positive case and the definitive pathology showed atypical nodular hyperplasia that could be a premalignant lesion). The diagnostic accuracy of this molecular method in only the 25 indeterminate nodules was 76% (19/25). No mutation was found in 3 FTCs. Among 107 PTCs, there was no significant association of the BRAF V600E mutation with the known risk factors. Conclusion Detection of the BRAF V600E mutation in FNAB specimens refines the FNAB‐cytology diagnosis, especially in a BRAF V600E mutation‐prevalent area. Direct DNA sequencing was a more reliable method than PCR‐RFLP for detecting the BRAF V600E mutation with a high sensitivity and specificity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2006.02646.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 171

Metadata

Authors
Chung, K., Yang, S. K., Lee, G. K., Kim, E. Y., Kwon, S., Lee, S. H., Park, D. J., Lee, H. S., Cho, B. Y., Lee, E. S., & Kim, S. W.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2006-09-04
Volume
65
Issue
5
Pages
660-666
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2069258306
Cited by
171
References
1
FWCI
6.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAFV600E mutation‐prevalent area. https://app.cochat.ai/papers/10.1111/j.1365-2265.2006.02646.x
The paper
Chung, K., Yang, S. K., Lee, G. K., Kim, E. Y., Kwon, S., Lee, S. H., Park, D. J., Lee, H. S., Cho, B. Y., Lee, E. S., & Kim, S. W. (2006). Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAFV600E mutation‐prevalent area. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2006.02646.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.